Predictors and Consequences of Global DNA Methylation in Cord Blood and at Three Years by Herbstman, Julie Beth et al.
Predictors and Consequences of Global DNA Methylation
in Cord Blood and at Three Years
Julie B. Herbstman1*, Shuang Wang2, Frederica P. Perera1, Sally A. Lederman3, Julia Vishnevetsky1,
Andrew G. Rundle4, Lori A. Hoepner1, Lirong Qu1, Deliang Tang1
1 Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York, United States of America, 2 Department of
Biostatistics, Columbia University Mailman School of Public Health, New York, New York, United States of America, 3 Institute of Human Nutrition, Columbia University
Medical Center, New York, New York, United States of America, 4 Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New
York, United States of America
Abstract
DNA methylation changes have been implicated in many common chronic diseases leading to the hypothesis that
environmental and age-related DNA methylation changes within individuals are involved in disease etiology. Few studies
have examined DNA methylation changes within an individual over time and all of these studies have been conducted in
adults. Here, we aim to characterize how global DNA methylation changes from birth to age three within a longitudinal
birth cohort study and to determine whether there are consistent predictors of DNA methylation levels measured three
years apart. We measured global DNA methylation in the same children at birth (cord blood) and again at three years of age
among 165 children, using an immunoassay. We found that on average, DNA methylation was significantly higher in blood
at age 3-years than in cord blood (p,0.01). However, for any individual child, the difference was less than would be
expected by chance. We found that pre-pregnancy BMI was negatively predictive of both cord and three-year DNA
methylation, even after statistical adjustment to account for the correlation between cord blood and three-year DNA
methylation. The biologic implications of small changes in global DNA methylation are unknown. However, the observation
that global DNA methylation levels persist within an individual from birth to age three supports the belief that factors that
influence global DNA methylation, including pre-pregnancy BMI, may confer long-term effects.
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Introduction
DNA methylation is an epigenetic process by which non-
sequence-based regulatory information can be mitotically trans-
ferred from mother to daughter cell. Involving the addition of a
methyl group at the 5-position of a cytosine-guanine (CpG)
dinucleotide, DNA methylation inhibits gene expression by
interfering with transcription binding proteins and is associated
with chromatin remodeling [1]. CpG sites are not evenly
represented throughout the genome. Over ninety percent of
methylated CpG sites lie within transposable, repetitive elements,
resulting in their silenced expression [2,3]. Other clusters occur in
gene promoters.
DNA methylation patterns are reset during early embryogen-
esis, allowing for tissue differentiation. Thereafter, DNA methyl-
ation is thought to be conserved, albeit labile, in somatic cells,
allowing the organism to adjust to changing developmental and
environmental conditions [1,4,5]. DNA methylation changes have
been implicated in many common chronic diseases leading to the
hypothesis that environmental and age-related DNA methylation
changes within individuals are involved in disease etiology [6].
Therefore, understanding how DNA methylation changes within
an individual over time may provide important links for etiological
research.
Relatively few studies have examined DNA methylation
changes within an individual over time and all of these studies
have been conducted in adults [3,7,8]. Given the theory that many
adult chronic diseases have developmental origins [9,10] and that
DNA methylation may be most vulnerable to insult when it is
undergoing developmental reprogramming, it has been suggested
that epigenetic mechanisms might be involved in the develop-
mental origins of health and disease [6]. Therefore, understanding
how DNA methylation changes early in life could provide critical
information linking prenatal exposure and subsequent disease or
dysfunction. Understanding factors that predict as well as those
that result from DNA methylation patterns early in life can
provide clues about disease etiology. For example, previous work
by Michels et al. indicates that maternal pre-pregnancy body mass
index (BMI) is associated with global DNA methylation measured
at birth, which is, in turn, associated with birth weight [11].
In this report, we aim to characterize how global DNA
methylation changes from birth to age three within our
longitudinal birth cohort study and to determine whether there
are consistent predictors of DNA methylation levels measured
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three years apart. Additionally, we sought to confirm the findings
concerning DNA methylation, pre-pregnancy BMI and birth
weight reported previously by Michels et al. Further, given the
theory that DNA methylation levels may persist throughout
childhood, we sought to determine whether maternal pre-
pregnancy BMI is also associated with global DNA methylation
measured in the offspring at three years of age.
Methods
Study Population
The Northern Manhattan Mothers and Newborns Study of the
Columbia Center for Children’s Environmental Health (CCCEH)
is a longitudinal cohort study of African American and Dominican
women who were recruited in the prenatal clinics of New York-
Presbyterian Medical Center, Harlem Hospital or their satellite
clinics, as previously described [12]. Eligible women were those
who did not smoke or use illicit drugs, aged 18–35 at delivery,
registered in the prenatal clinics by the 20th week of pregnancy,
free of reported diabetes, hypertension and HIV, and had resided
in the Washington Heights, Central Harlem or the South Bronx
areas of New York City for at least one year. Eligible women who
gave informed consent were considered ‘initially enrolled’. Women
who completed the prenatal questionnaire and provided maternal
and/or umbilical cord blood were considered ‘fully enrolled’ [13].
For this study, we investigated n = 279 children with available data
on umbilical cord blood DNA that had been isolated from total
white blood cells (WBC). Among these children, 165 also had
DNA from blood collected at three years of age. Participants with
cord blood DNA methylation measurements were not significantly
different from the underlying cohort with respect to demographic
characteristics; however, among those with cord blood DNA
methylation measurements, children with three year measure-
ments had mothers with greater average weight gain during
pregnancy (36.5 lbs vs. 30.9 lbs) (Table S1 in File S1). All study
participants provided their written informed consent. In addition,
the women enrolled in this study provided consent on behalf of
their children, who at age 3 were too young to provide assent. This
protocol and related informed consent procedure is approved by
the Columbia University Medical Center Institutional Review
Board.
DNA methylation
DNA isolated from umbilical cord blood leukocytes (WBC) was
analyzed for global DNA methylation using the MethylampTM
Global DNA Methylation Quantification Kit (Epigentek Group
Inc, NY). This method quantifies the methylated fraction of DNA
using an ELISA-like reaction. The proportion of methylated DNA
in the full sample is determined by plotting the intensity of the
optical density generated from the reaction in comparison to the
linear range of a standard curve produced using a methylated
DNA control. Using this assay, DNA methylation is represented as
the ratio of methylated DNA per 100 nanograms (ng) of total
DNA. In humans, with the exception of stem cells, which make up
a very small proportion of cord blood, DNA methylation occurs
exclusively at cytosine-guanine dinucleotides [14,15]. As CpG
dinucleotides are underrepresented in the genome, the proportion
of total DNA that would be expected to be methylated is small.
Reference values provided by the manufacturer range from 0.8–
3%. Samples were run in duplicate, and cord and three year
samples from the same children were run on the same reaction
plate to minimize the plate-to-plate variation. The average of the
duplicate measures was used in analyses. In this sample, the
coefficient of variation (calculated using the method described in
[16]) between replicates on the same plate was 16%.
Birth outcomes and covariates
Research workers abstracted information about birth outcomes
including gestational age at delivery, birth weight, birth length,
and head circumference from maternal and infant medical records
after delivery. We also collected additional information about
important covariates including infant sex, maternal height, pre-
pregnancy weight, total gestational weight gain (weight closest to
delivery minus pre-pregnancy weight), and complications of
pregnancy and delivery. Standardized pre-pregnancy body mass
index (BMI) categories were grouped according to the recom-
mendations of the CDC (2011) as underweight, normal weight,
overweight and obese [17], using maternal height (as measured by
research workers) and pre-pregnancy weight (self-reported).
Bilingual (Spanish and English) research workers administered a
45-minute questionnaire during the last trimester of pregnancy.
This questionnaire included demographic information, history of
active and passive smoking, and socioeconomic information
related to income and education. A follow-up questionnaire at
6 months, 1, 2, and 3 years provided additional information about
breast feeding duration and postnatal environmental tobacco
smoke exposure (ETS). Prenatal exposure to environmental
polycyclic aromatic hydrocarbons (PAH) was assessed using a
backpack monitor for 48 hours during the second trimester of
pregnancy, as previously described in detail [12,13]. We also used
the woman’s questionnaire-based report of smoking in the home at
three years to account for postnatal exposure to passive smoke.
Statistical analyses
Descriptive statistics were calculated for DNA methylation in
cord and three-year blood samples. Cord and three-year DNA
methylation levels were initially compared statistically using
Pearson’s and Spearman correlation coefficients. To test the
hypothesis that the difference between DNA methylation levels in
cord and three-year samples from the same individuals was
significantly smaller than the difference between DNA methylation
levels in cord and three-year samples from different individuals, we
conducted permutation analyses. More specifically, with 165
children that have both cord and three-year DNA methylation
samples, we held the cord DNA methylation data intact and
shuffled the three-year DNA methylation to generate cord and
three-year pairing from different individuals, which we call
random pairs. We repeated the permutation 10,000 times, which
generated a distribution of the average difference in DNA
methylation between 165 randomly paired cord and three-year
samples from different children. We then compared the average
difference in DNA methylation between the 165 observed cord
and three-year pairs from the same individuals to the 10,000
average differences in DNA methylation between the 165
randomly paired cord and three-year samples from different
individuals.
Univariate associations between demographic, socioeconomic,
and other potential covariates and cord and three-year DNA
methylation, respectively, were explored using Student’s t-test and
simple linear regression, as appropriate. In linear regressions,
DNA methylation measures were natural log-transformed to meet
normality assumptions. Change in DNA methylation was calcu-
lated as the absolute difference in DNA methylation from birth to
three years. To further determine which factors predicted cord
and three-year DNA methylation or the change in DNA
methylation over time, respectively, we used multiple linear
regression models where natural log-transformed DNA methyla-
Cord Blood and Three Year Global DNA Methylation
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tion (either cord or three-year or the change in DNA methylation)
was the dependent variable. In the model where three-year natural
log-transformed DNA methylation was the dependent variable, we
constructed a separate model that included cord natural log-
transformed DNA methylation as a covariate to determine the
independent influence of other covariates on DNA methylation
measured at three years. We used principal components analysis to
deconstruct the variation associated with plate-to-plate variation
associated with technical variability [18,19]. We then used the
single factor variable that accounted for 98% of the variation
across plates as a covariate in all analyses other than the cord-three
year DNA methylation comparisons which were matched on plate
by design.
Finally, we evaluated the relationships between cord blood
DNA methylation and birth outcomes, including gestational age at
delivery, birth weight, length, head circumference and ponderal
index (birth weight in g/(length in cm)3 x 100), a measure of body
proportions at birth. Global DNA methylation measured in cord
blood, an independent variable, was log transformed to stabilize
the variance. Covariates were included in the birth outcome
models if they were associated with the outcome in bivariate
analysis with p,0.10 and changed the beta coefficient represent-
ing the relationship between cord blood DNA methylation and
each birth outcome more than 5%.
Results
The mean of cord blood DNA methylation is 1.77 ng/100 ng
total DNA (1.84 ng/100 ng total DNA in the subset of partic-
ipants for whom we also have DNA at three years, ‘‘subset’’),
Table 1. Compared to cord blood, average peripheral blood
DNA methylation is significantly higher in the same children at
age 3 (mean at 3 years: 2.72 ng/100 ng total DNA, paired t-test:
p,0.01). Cord and three-year DNA methylation are moderately
but significantly correlated (Pearson’s R = 0.41 (p,0.001), Spear-
man R = 0.30 (p,0.001)), Figure 1. Cord DNA methylation is a
significant predictor of three-year DNA methylation (b= 0.27,
p,0.001 per increase in log-transformed cord DNA methylation).
The average change in DNA methylation measured in cord
blood and again in blood at age three in the same individuals was
0.88 ng/100ng total DNA (standard deviation = 4.32). The range
was 212.62 to 31.11, such that two-thirds of individuals had
global DNA methylation that increased from cord to three years
and one-third of individuals had DNA methylation that decreased
during this same time period. However, the majority of individuals
(62%) had DNA methylation that changed very little (within 1 ng/
100ng total DNA) from birth to age 3 while 12% had a negative
change greater than 1 ng/100 ng total DNA and 27% had a
positive change greater than 1 ng/100 ng total DNA). In the
permutation analyses to assess whether the difference between
DNA methylation levels in cord and three-year samples from the
same individuals were significantly smaller than the difference
between DNA methylation levels in cord and three-year samples
from different individuals, we compared the 10,000 permuted
mean difference from random pairs and one mean difference from
the observed pairs. Figure 2 shows the distribution of absolute
mean differences in DNA methylation from the 10,000 random
pairings of cord and three-year samples. The solid red bar
indicates the actual mean absolute difference in DNA methylation
from birth to age three from the same individual. The averaged
absolute mean difference between random cord and three-year
pairs over 10,000 permutations was 2.33 ng/100 ng total DNA,
which was significantly greater than the observed absolute mean
difference (1.81 ng/100ng total DNA, (p,0.01)).
The factors that predict cord and three year DNA methylation
are shown in Tables 2 and 3. In univariate analyses after
accounting for inter-plate variation, only pre-pregnancy weight
and pre-pregnancy BMI predicted lower global DNA methylation
in cord blood. Pre-pregnancy BMI was inversely associated with
DNA methylation (cord p = 0.03, subset p,0.01, and three-year
p = ,0.01). When examining BMI group, women who were obese
prior to pregnancy had the lowest DNA methylation (compared to
women of normal weight: full p = 0.15, subset p = 0.04, and three-
year p,0.01).
At three years, we found that having a smoker in the home at
three years was (non-significantly) associated with lower three year
DNA methylation (p = 0.08) and having breast fed more than
3 months was (non-significantly) associated with higher three year
DNA methylation (p = 0.07) compared with not having breast fed
at all. Previously, we reported an association between prenatal
PAH and lower cord blood DNA methylation [20]. Among those
for whom we measured three year DNA methylation, high PAH
(above the population median) was not associated with lower DNA
methylation at three years.
In multiple linear regression models (Table 4), pre-pregnancy
BMI was significantly predictive of both cord and three year DNA
methylation (full p = 0.01, subset p = 0.02, three-year p,0.01).
Because we observed a significant positive association between
cord and three year DNA methylation (Table 1, Figures 1 and
2), we explored whether cord blood DNA methylation was an
independent predictor of three year DNA methylation or whether
there is evidence indicating that it is on the causal pathway
between pre-pregnancy BMI and three year DNA methylation.
Adjusting for other covariates listed in Table 4, the beta
coefficient for pre-pregnancy BMI on log-transformed DNA
methylation at three years was 20.069, with a 95% CI of
20.102, 20.036. After further adjusting for log-transformed cord
DNA methylation, the coefficient for pre-pregnancy BMI was
virtually unchanged (20.062, 95% CI: 20.096, 20.029), indicat-
ing that cord methylation does not confound the observed
Figure 1. Association between cord and three-year DNA
methylation.
doi:10.1371/journal.pone.0072824.g001
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association between pre-pregnancy BMI and three year methyl-
ation. In Figure S1A-D in File S1, we present the partial
regression plots (reflecting the regression coefficient from the
multiple linear regression models) presenting the association of
pre-pregnancy BMI and DNA methylation in cord and three-year
DNA. Being a former smoker and concurrent ETS exposure
(defined as having a smoker in the home at three years) were also
predictors of lower global DNA methylation in the offspring at
three years (p = 0.10 and p = 0.08, respectively).
We explored the factors that influence the absolute value of the
difference between DNA methylation measured in cord blood and
DNA methylation measured in blood collected from the same
children at age 3 (Table S2 in File S1 ). Pre-pregnancy BMI
predicted a smaller absolute change in DNA methylation from
birth to three years. Breast feeding duration during the first year
was associated with a larger absolute change in DNA methylation.
In Table 5, we present the univariate and adjusted association
between cord DNA methylation and birth outcomes including
gestational age, birth weight, birth length, ponderal index, and
head circumference. In no case was cord DNA methylation
significantly associated with any of these birth outcomes, either
before or after adjusting for possible confounders.
Discussion
The goals of this analysis were three-fold. First, we explored the
relationship between global DNA methylation measured in the
same children at birth (cord blood) and again at three years of age.
We found that on average, DNA methylation was significantly
higher in blood at age 3 years than in cord blood. However, for
any individual child, the difference was less than would be
expected by chance. Second, we explored the factors that predict
global DNA methylation at birth and three years. We found that
pre-pregnancy BMI was negatively predictive of both cord and
three-year DNA methylation, even after statistical adjustment to
account for the correlation between cord blood and three-year
DNA methylation. Finally, we examined whether global DNA
methylation in cord blood is a risk factor for adverse birth
outcomes. We did not find any evidence that cord blood DNA
methylation was associated (either positively or negatively) with
birth outcomes.
Changes in epigenetic marks have been proposed to be a
biologic mechanism by which exposures affect health and disease
across the life course [6]. Generally, epigenetic marks are thought
to be conserved and perpetuated in daughter cells, thereby
predisposing cells towards an altered gene expression when the
affected genes are developmentally signaled [21]. However, there
may be some alterations in epigenetic marks that are more
transient. If these changes occur during developmentally impor-
tant periods, they may trigger a biologic cascade thereby
influencing downstream health. Thus far, there has been little
documentation characterizing the persistent or transient nature of
DNA methylation during early child development.
Because global DNA hypomethylation is a hallmark of many
age-related diseases [22–24] a number of studies have examined
changes in DNA methylation over time in older populations
[3,7,8]. Bollati et al. reported a gradual decrease in DNA
methylation of Alu (but not LINE-1) measured in WBC by
pyrosequencing repetitive elements assessed an average of 8 years
Table 1. Summary Statistics.
Cord DNA Methylation
(ng/100ng total DNA)
Cord DNA Methylation (subseta)
(ng/100ng total DNA)
DNA Methylation at 3 yrs
(ng/100ng total DNA)
N 279 165 165
Mean (SD) 1.77 (2.37) 1.84 (2.93) 2.72 (4.58)
Geometric mean 1.13 (3.14) 1.13 (3.60) 1.55 (3.19)
1st quartile 0.84 0.72 1.14
Median 1.34 1.27 1.94
3rd quartile 2.18 2.23 2.87
Spearman R (p-value) 0.30 (,0.01)
Pearson’s R (p-value) 0.41 (,0.01)
Summary Statistics, where subset refers to those with both cord and three year DNA methylation measures available.
aThe ‘subset’ includes children who have contributed both cord and three year DNA samples.
doi:10.1371/journal.pone.0072824.t001
Figure 2. Permutation analysis. Gray histogram depicts the
distribution of absolute mean differences in DNA methylation from
the 10,000 random pairings of cord and three-year samples. The solid
red bar indicates the actual mean absolute difference in DNA
methylation from birth to age three in the same individual.
doi:10.1371/journal.pone.0072824.g002
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apart among men between the ages of 55 and 92. These changes
over time were noted to be small relative to the inter-individual
variability of global DNA methylation [3]. Bjornnson et al. studied
individuals aged 69–96 whose global DNA methylation was
measured in WBC 11 years apart. They found that average DNA
methylation was equally likely to increase or decrease. Among
approximately one third of the individuals studied, DNA
methylation changed more than 10%. Using a different population
of individuals clustered within families whose WBC global DNA
methylation was measured twice over an average of 16 years,
Bjornnson et al. showed that DNA methylation change over time
tended to cluster within families not necessarily living in the same
household. These data suggest that global DNA methylation
maintenance is a heritable trait [7]. Wu et al. described global
DNA methylation in peripheral blood mononuclear cells (a subset
of total WBC) measured three ways (LUMA, LINE-1 by
pyrosequencing and Sat2 by methylite) in adults at two time
points 8.6 years apart. Using LUMA, the results were similar to
those of Bjornnson et al.; approximately 30% had DNA
methylation changes greater than 10% compared to 60% using
Table 2. Univariate a Predictors of Cord and Three Year DNA Methylation (categorical).
Cord DNA Methylation
(ng/100ng total DNA)
Cord and Three Year DNA
Methylation (ng/100ng total DNA)
Cord (subset)b Three Year
N % Mean SD N % Mean SD Mean SD
Maternal Education
,HS 100 36.0 1.03 1.12 55 33.3 0.90 1.17 1.48 1.16
HS 96 34.5 1.17 1.12 67 40.6 1.18 1.15 1.87 1.15
.HS 82 29.5 1.20 1.13 43 26.1 1.00 1.20 1.22 1.19
Marital Status
Married/Cohab. 206 75.2 1.04 1.15 119 73.0 0.94 1.19 1.56 1.19
Unmarried 68 24.8 1.15 1.08 44 27.0 1.05 1.11 1.52 1.11
Material Hardship
No 159 57.0 1.07 1.09 93 56.4 0.97 1.13 1.60 1.12
Yes 120 43.0 1.21 1.11 72 43.6 1.13 1.15 1.48 1.14
Public Assistance
No 23 8.3 1.14 1.26 10 6.1 1.60 1.45 1.58 1.43
Yes 255 91.7 1.12 1.07 155 93.9 1.00 1.10 1.54 1.09
Ethnicity
Dominican 193 69.2 1.16 1.08 111 67.3 1.06 1.12 1.68 1.11
African American 86 30.8 1.06 1.13 54 32.7 0.98 1.17 1.30 1.17
BMI
Underweight 14 5.0 1.19 1.35 9 5.5 1.05 1.47 1.49 1.43
Normal weight 125 44.8 1.28 1.10 74 44.8 1.31 1.14 2.01 1.13
Overweight 62 22.2 0.97 1.15 40 24.2 0.84 1.20 1.85 1.18
Obese 78 28.0 1.02 1.13 42 25.5 0.82 1.20 0.83 1.18
Nulliparous
No 137 49.5 1.21 1.10 79 48.17 1.16 1.14 1.68 1.14
Yes 140 50.5 1.04 1.10 85 51.83 0.91 1.14 1.42 1.13
Former smoker
No 212 81.9 1.12 1.08 126 82.9 1.07 1.11 1.78 1.11
Yes 47 18.1 1.18 1.18 26 17.1 0.85 1.26 1.00 1.25
ETS
No 181 66.1 1.11 1.09 104 64.2 0.99 1.12 1.63 1.12
Yes 93 33.9 1.15 1.12 58 35.8 1.12 1.17 1.46 1.16
Sex
Male 130 46.6 1.14 1.10 78 47.3 0.96 1.14 1.50 1.14
Female 149 53.4 1.12 1.10 87 52.7 1.10 1.13 1.59 1.13
Univariate a Categorical Predictors of Cord and Three Year DNA Methylation, geometric mean and SD.
aAnalyses corrected for inter-plate variation.
bThe ‘subset’ includes children who have contributed both cord and three year DNA samples.
Abbreviations: Yr (year); HS (High School); BMI (Body Mass Index); ETS (Environmental Tobacco Smoke).
doi:10.1371/journal.pone.0072824.t002
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Sat2 and 4% using Line-1 [8]. While all of these analytic methods
are considered surrogate measures of global DNA methylation,
each measures a different underlying biologic construct, which
may explain the discrepant findings.
Here, we report changes in global DNA methylation measured
at birth and age three. This is an important life stage to examine,
as DNA methylation marks may be programmed during
development – a fluid process that does not end at birth – and
maintained thereafter. Because much of development, including
tissue differentiation, is epigenetically driven [21], factors that
influence epigenetic marks and potential plasticity during this
period of flux may be especially important. The significant relation
of maternal pre-pregnancy BMI and maternal age at delivery to
DNA methylation at birth and at three years may be an example
of this phenomenon. In addition, it is known that the composition
of lymphocytes differs between cord and peripheral blood [25] and
DNA methylation differs by cell type [8]. On average, the majority
of leukocytes at birth are neutrophils (61%), followed by
lymphocytes (31%), monocytes (6%), and eosinophils (2%). At
age 2–4 years, the lymphocytes dominate (50–59%), followed by
neutrophils (33–42%), monocytes (5%), and eosinophils (2%) [26].
A recent report by Reinius et al. indicates that methylation at CpG
sites measured on the Illumina Infinium Human Methylation
450K chip tend to differ by cell lineage [27]. However, only a
quarter of the CpG sites represented on the Infinium array
represent intragenic regions [28]. Because the majority of
methylated CpG sites are located in intergenic regions to silence
transposable, repetitive elements, it is not clear that cell-specific
changes in DNA methylation on CpG sites located in promotors
or gene bodies would have a profound impact on a measure of
global DNA methylation [2]. It may be reasonable to speculate
that intergenic regions would be preferentially silenced irrespective
of cell type. However, because DNA methylation in this study was
measured in total blood leukocytes (WBC), we cannot rule out the
possibility that the compositional change from birth to three years
may explain the average increase in DNA methylation we
observed. Unfortunately, differential blood counts were not
available in this study to further explore this issue. The intra-
individual change in DNA methylation between birth and three
years that we observed was, overall, fairly small compared to the
inter-individual differences. Similar to the report by Wu et al., the
higher the DNA methylation level we observed at baseline (i.e., at
birth), the smaller the change in DNA methylation measured at
three years.
The observed protracted relation of pre-pregnancy BMI to
global DNA methylation measured in both cord and three-year
blood in the offspring is of particular note. A sub-optimal
intrauterine environment resulting from maternal obesity could
predispose the newborn infant and child to a variety of adverse
health outcomes [29,30]. Obesity constitutes a chronic state of
low-grade inflammation, which is a critical risk factor for insulin
resistance and other metabolic disorders [31]. Additionally,
maternal obesity is likely to be related, at least in part, to maternal
nutritional factors. Both chronic inflammation [32] and maternal
nutrition [33] have been associated with changes in epigenetic
markers. Currently, it is not known how maternal obesity prior to
pregnancy may change DNA methylation in the offspring and it is
also not known whether or what type of risk this change confers on
the health of the offspring over his/her life course. We observed
associations between pre-pregnancy BMI and DNA methylation at
three years that occurred independently of the apparent mainte-
nance of DNA methylation.
The World Health Organization has estimated that one third of
U.S. women of reproductive age (20 to 44 years) are obese [34]
and obesity rates assessed at the start of pregnancy in the
Pregnancy Risk Assessment Monitoring System (PRAMS) have
increased 70% from 1993 to 2003 [35]. Given the prevalence of
pre-pregnancy obesity and its apparent association with epigenetic
modification at birth and during childhood, additional research
confirming this association and understanding the health effects
conferred are warranted.
In contrast to the report by Michels et al. [11], we did not find
an association between global DNA methylation measured in cord
blood and birth weight (or any other birth outcome). A number of
differences in study design may account for the discordant findings
– most notably, the method used to assess global DNA
methylation. Michels et al. estimated global DNA methylation
using LINE-1 by pyrosequencing in contrast to our immunopre-
cipitation-based assay. As Wu et al. demonstrated [8], not all
measures of global DNA methylation estimate the same biologic
construct, despite the fact that they purport to estimate global
DNA methylation. Differences in the method used to approximate
global DNA methylation may alone account for differences in the
associations observed. Additionally, Michels et al. characterized
birth weight using standardized categories for low (,2500g) and
high (.4000g) birth weight. In this sample, we do not have
enough children falling in these categories to analyze our data in a
similar fashion. Birth weight, itself, is not a mechanism but rather a
Table 5. Association with Birth Outcomes a.
Model 1b Model 2c Model 3d
N Beta 95% CI Beta 95% CI Beta 95% CI
Gestational Age 252 0.020 20.114, 0.154 0.025 20.109, 0.159 0.022 20.113, 0.156
Birth Weight 249 236.736 280.868, 7.396 225.679 269.404, 18.047 228.452 272.064, 15.161
Birth Length 236 20.008 20.306, 0.290 0.048 20.250, 0.346 0.049 20.248, 0.347
Ponderal Index 237 20.213 20.643, 0.217 20.283 20.695, 0.130 20.274 20.688, 0.140
Head Circumferencee 230 20.154 20.296, 20.012 20.120 20.256, 0.016 20.128 20.263, 0.006
Cord DNA Methylation (ng/100ng total DNA) and Birth Outcomes a.
aAll multivariate models corrected for inter-plate variation.
bModel 1 adjusted for gestational age (except in the model where gestational age is the dependent variable) and plate.
cModel 2 adjusted for covariates in Model 1 plus maternal height, pre-pregnancy BMI, maternal age at delivery, ethnicity, sex, and public assistance.
dModel 3 adjusted for covariates in Model 2 plus total Polycyclic Aromatic Hydrocarbons and Environmental Tobacco Smoke.
eDelivery mode added to all models where head circumference is the dependent variable.
doi:10.1371/journal.pone.0072824.t005
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biomarker representing, among other things, the degree of
restriction of the intrauterine environment [36]. If DNA methyl-
ation and birth weight are related, it may only be evident when
comparing categorical extremes. Finally, covariates included in the
final models may account for differences in the conclusions. For
example, we included pre-pregnancy BMI as a likely confounder
whereas the Michels et al. analysis of birth weight did not [11].
There are a few aspects of our study that warrant a cautious
interpretation of the findings. It is possible that underlying health
conditions present at the time the blood sample was collected
might influence the cellular constituency of the blood, influencing
DNA methylation measured; however, these conditions (e.g.,
infection) are likely to be random rather than systematic. It should
also be noted that variation in DNA methylation between birth
and three years is likely a function of heritability as well as
additional exposures occurring during these early years of life.
While we were able to evaluate the impact of some of the non-
heritable factors (e.g., exposure to smoke in the home, breast
feeding), there are many postnatal exposures that we were not able
to measure; whether any of these exposures confound observed
associations is not known. Additionally, our pre-pregnancy
maternal weight and height measures were self-reported, which
may result in under-estimating weight and BMI and over-
estimating height [37]. This potential misclassification is unlikely
to be related to global DNA methylation levels (which are
unknown to the study participants) therefore biasing the results to
the null. Finally, global DNA methylation is an informative but
limited biomarker whose clinical interpretation is not fully
understood. It provides no indication of which genes are impacted,
limiting our ability to interpret or predict potentially related health
consequences.
Conclusion
Global DNA methylation is a non-specific biomarker that is a
broad indicator of early biological changes that may affect an
array of functions in the offspring. The biologic implications of
small changes in global DNA methylation are unknown. However,
the observation that global DNA methylation levels persist within
an individual from birth to age three supports the belief that
factors that influence global DNA methylation may confer long-
term effects. Therefore, the effect of these factors (including pre-
pregnancy BMI) on global DNA methylation at birth and at three
years deserves further study. Specifically, examining the DNA
methylation of specific genes or regions of the genome that are
influenced by pre-pregnancy BMI could contribute to the
development of hypotheses about how the offspring of overweight
women may be affected across the life course.
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